Zhengye Biotechnology Holding Ltd. (ZYBT)

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$0.74
Day's range
$0.81

Zhengye Biotechnology Holding Ltd. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
XTX TOPCO LTD 05/15/2026 44.15 K $41.27 K   -25.54% 0.09%
WINTON GROUP LTD 05/12/2026 33.39 K $31.21 K   -47.25% 0.07%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 29.07 K $27.17 K   0.00% 0.06%
UBS GROUP AG 05/05/2026 8.04 K $7.51 K   -11.84% 0.02%
TOWER RESEARCH CAPITAL LLC (TRC) 05/15/2026 4.91 K $4.59 K   122.56% 0.01%
ROYAL BANK OF CANADA 05/15/2026 1.23 K $1.00 K   100.00% 0.00%
MORGAN STANLEY 05/15/2026 261 $244   -83.76% 0.00%
CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD 05/11/2026 1 $1   0.00% 0.00%
JPMORGAN CHASE & CO 05/13/2026 0 $0   -100.00% 0.00%
INVESCO LTD. 05/12/2026 0 $0   -100.00% 0.00%
CITADEL ADVISORS LLC 05/15/2026 0 $0   -100.00% 0.00%

Zhengye Biotechnology Holding Ltd. institutional Ownership - FAQ's

During the previous two years, 11 institutional investors and hedge funds held shares of Zhengye Biotechnology Holding Ltd.. The most heavily invested institutionals were:

XTX Topco Ltd: 44,146

WINTON GROUP Ltd: 33,389

GEODE CAPITAL MANAGEMENT, LLC: 29,068

UBS Group AG: 8,036

Tower Research Capital LLC (TRC): 4,912

ROYAL BANK OF CANADA: 1,230

0.26% of Zhengye Biotechnology Holding Ltd. stock is owned by institutional investors.

Institutional investors have bought a total of 121.04 K shares in the last 24 months. This purchase volume represents approximately $90.78 K in transactions.